sarilumab
Showing 1 - 23 of 23
Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)
Not yet recruiting
- Melanoma
- Unresectable Melanoma
- Sarilumab
- +2 more
-
Los Angeles, California
- +3 more
Aug 4, 2022
Application of N-of-1 Rheumatoid Arthritis
Not yet recruiting
- Arthritis, Rheumatoid
- Adalimumab
- +2 more
-
Boston, MassachusettsTufts Medical Center
Aug 24, 2023
Morphea, Plaque Form Trial in Boston (Sarilumab)
Withdrawn
- Morphea, Plaque Form
- Sarilumab
-
Boston, MassachusettsCURTIS (Massachusetts General Hospital)
Aug 31, 2021
Skin Inflammation, Allergic Contact Dermatitis Trial in Worcester (drug, other, device)
Recruiting
- Skin Inflammation
- Allergic Contact Dermatitis
- Squaric Acid Dibutyl Ester
- +12 more
-
Worcester, MassachusettsUniversity of Massachusetts Chan Medical School
Sep 6, 2022
Arthritis, Rheumatoid, Interaction Trial in Esbjerg, Odense, Sønderborg (Tocilizumab, Sarilumab)
Terminated
- Arthritis, Rheumatoid
- Interaction
- Tocilizumab
- Sarilumab
-
Esbjerg, Region Of Southern Denmark, Denmark
- +2 more
Jan 20, 2023
Juvenile Idiopathic Arthritis Trial in Worldwide (Sarilumab)
Active, not recruiting
- Juvenile Idiopathic Arthritis
- Sarilumab
-
Los Angeles, California
- +34 more
May 10, 2022
Covid-19 Trial in Madrid (Sarilumab, Standar of care)
Completed
- Covid-19
- Sarilumab
- Standar of care
-
Madrid, SpainHospital Universitario de la Princesa
Feb 10, 2021
COVID-19 Drug Treatment Trial in Pamplona, Madrid (Sarilumab)
Unknown status
- COVID-19 Drug Treatment
- Sarilumab
-
Pamplona, Navarra, Spain
- +1 more
Dec 14, 2020
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))
Completed
- Rheumatoid Arthritis
- Sarilumab
- +3 more
-
Covina, California
- +85 more
Mar 15, 2022
Rheumatoid Arthritis Trial in Aventura (Sarilumab)
Unknown status
- Rheumatoid Arthritis
- Sarilumab
-
Aventura, FloridaAARDS Research, Inc
Aug 10, 2020
COVID19, SARS-CoV-2 Infection Trial in France (Sarilumab, Azithromycin, Hydroxychloroquine)
Suspended
- COVID19
- SARS-CoV-2 Infection
- Sarilumab
- +2 more
-
Bobigny, France
- +4 more
May 4, 2020
Corona Virus Infection Trial in Le Kremlin-Bicêtre, Paris (Sarilumab)
Unknown status
- Corona Virus Infection
- Sarilumab
-
Le Kremlin-Bicêtre, Ile De France, France
- +3 more
Apr 14, 2020
Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Placebo, Golimumab)
Terminated
- Rheumatoid Arthritis
- Sarilumab
- +4 more
-
Freehold, New Jersey
- +13 more
Jul 31, 2017
Ankylosing Spondylitis Trial in Worldwide (Sarilumab)
Terminated
- Ankylosing Spondylitis
- Sarilumab
-
Bridgewater, New Jersey
- +11 more
May 24, 2017
Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Etanercept, Methotrexate)
Terminated
- Rheumatoid Arthritis
- Sarilumab
- +5 more
-
Birmingham, Alabama
- +256 more
Jun 28, 2017
Rheumatoid Arthritis Trial in Worldwide (Sarilumab, , hydroxychloroquine)
Completed
- Rheumatoid Arthritis
- Sarilumab
- +5 more
-
Anniston, Alabama
- +195 more
Jul 7, 2017
Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Placebo (for sarilumab), Methotrexate)
Completed
- Rheumatoid Arthritis
- Sarilumab
- +3 more
-
Anniston, Alabama
- +261 more
Jun 27, 2017